News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
460,626 Results
Type
Article (22271)
Company Profile (143)
Press Release (438212)
Section
Business (148483)
Career Advice (1178)
Deals (27242)
Drug Delivery (98)
Drug Development (58929)
Employer Resources (95)
FDA (9811)
Job Trends (10001)
News (248786)
Policy (21527)
Tag
Academia (949)
Alliances (35323)
Alzheimer's disease (783)
Approvals (9806)
Artificial intelligence (129)
Bankruptcy (231)
Best Places to Work (7237)
Breast cancer (129)
Cancer (1076)
Cardiovascular disease (93)
Career advice (973)
Cell therapy (187)
Clinical research (48752)
Collaboration (442)
Compensation (210)
COVID-19 (1339)
C-suite (137)
Data (1084)
Diabetes (143)
Diagnostics (3362)
Drug pricing (103)
Earnings (61536)
Employer resources (87)
Events (72091)
Executive appointments (473)
FDA (10343)
Funding (361)
Gene therapy (144)
GLP-1 (570)
Government (2066)
Healthcare (9442)
Infectious disease (1414)
Inflammatory bowel disease (85)
Interviews (156)
IPO (12086)
Job creations (3048)
Job search strategy (882)
Layoffs (315)
Legal (5683)
Lung cancer (150)
Manufacturing (186)
Medical device (5403)
Medtech (5407)
Mergers & acquisitions (15441)
Metabolic disorders (455)
Neuroscience (1059)
NextGen: Class of 2025 (3441)
Non-profit (1478)
Northern California (1297)
Obesity (278)
Opinion (190)
Patents (112)
People (44082)
Phase I (15132)
Phase II (21011)
Phase III (16445)
Pipeline (592)
Policy (89)
Postmarket research (1863)
Preclinical (5561)
Radiopharmaceuticals (193)
Rare diseases (235)
Real estate (4249)
Regulatory (14892)
Research institute (997)
Resumes & cover letters (177)
Southern California (1137)
Startups (2482)
United States (11728)
Vaccines (268)
Weight loss (219)
Date
Today (9)
Last 7 days (427)
Last 30 days (1781)
Last 365 days (23240)
2025 (3103)
2024 (23665)
2023 (27020)
2022 (35764)
2021 (37950)
2020 (35282)
2019 (27892)
2018 (21424)
2017 (22405)
2016 (21164)
2015 (25311)
2014 (20573)
2013 (17306)
2012 (18631)
2011 (19163)
2010 (18163)
Location
Africa (508)
Arizona (98)
Asia (29967)
Australia (3987)
California (2938)
Canada (1385)
China (272)
Colorado (140)
Connecticut (142)
Europe (61838)
Florida (448)
Illinois (268)
Indiana (187)
Japan (102)
Maryland (389)
Massachusetts (2423)
Michigan (121)
Minnesota (192)
New Jersey (1036)
New York (846)
North Carolina (590)
Northern California (1297)
Ohio (105)
Pennsylvania (647)
South America (759)
Southern California (1137)
Texas (417)
Virginia (87)
Washington State (268)
460,626 Results for "nutra pharma corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
Trump’s Whiplash Policies Keep Pharmas on Their Toes
As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives find themselves faced with policy questions ranging from the Inflation Reduction Act to RFK Jr.
February 12, 2025
·
4 min read
·
Annalee Armstrong
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
GLP-1
Lilly, Novo Skew Overall Pharma Trends With Colossal GLP-1 Sales Growth
From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved into a new pharma stratosphere, far eclipsing their rivals.
February 12, 2025
·
2 min read
·
Annalee Armstrong
China
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
January 7, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
February 7, 2025
·
4 min read
Press Releases
NervGen Pharma Grants Stock Options
February 18, 2025
·
1 min read
NextGen
After 10 Years of Hard Work, COUR Treads Into Pharma’s Myasthenia Gravis Territory
COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission with a series A raise.
February 18, 2025
·
2 min read
·
Annalee Armstrong
NervGen Pharma Grants Stock Options.
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that the company has granted 950,000
June 7, 2024
·
1 min read
Press Releases
Sharp Therapeutics Corp. Completes Share Consolidation
January 27, 2025
·
3 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
1 of 46,063
Next
